2007
DOI: 10.2146/ajhp060548
|View full text |Cite
|
Sign up to set email alerts
|

Potential drug–drug interactions within Veterans Affairs medical centers

Abstract: The analysis of pharmacy records of veterans who filled prescriptions at the outpatient settings within VAMC found an overall rate of 2.15% for potential DDIs. Case-exposure rates were greatest for veterans receiving SSRIs and MAOIs, ganciclovir and zidovudine, anticoagulants and thyroid hormones, and warfarin and nonsteroidal antiinflammatory drugs.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
30
1

Year Published

2008
2008
2022
2022

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 30 publications
(32 citation statements)
references
References 45 publications
1
30
1
Order By: Relevance
“…1,5,7,19,20 A study of pharmacy records from VA ambulatory care clinics found that the rate of exposure to 25 potential DDIs was 2.2%. 20 Another study on the frequency of potential DDIs in a pharmacy benefits manager's drug database revealed that the potential DDI pair with the highest prevalence rate (warfarin/non-steroidal anti-inflammatory drug) occurred at a rate of 279 per 100,000 persons. 19 Studies documenting the dangers of DDIs underscore the need to be able to detect and prevent potential drug interactions.…”
Section: Discussionmentioning
confidence: 99%
“…1,5,7,19,20 A study of pharmacy records from VA ambulatory care clinics found that the rate of exposure to 25 potential DDIs was 2.2%. 20 Another study on the frequency of potential DDIs in a pharmacy benefits manager's drug database revealed that the potential DDI pair with the highest prevalence rate (warfarin/non-steroidal anti-inflammatory drug) occurred at a rate of 279 per 100,000 persons. 19 Studies documenting the dangers of DDIs underscore the need to be able to detect and prevent potential drug interactions.…”
Section: Discussionmentioning
confidence: 99%
“…18 A list of 25 clinically important DDIs that were most likely to be encountered in ambulatory care settings was used in this study. 19 Anonymous pharmacy records for VA health care system beneficiaries were provided at the national level by VA PBM, which included data from the surveyed VAMCs related to veterans who filled prescriptions during the period from July 1, 2003, to June 30, 2004.…”
Section: Methodsmentioning
confidence: 99%
“…Even though DDIs are considered as preventable medication-related problems, studies found that up to 11% of patients experience symptoms associated with DDI and these are responsible for nearly 2.8% of hospital admissions [8]. Monitoring of DDIs may improve the quality of prescribing and dispensing, and it might form a basis for education focused on appropriate prescribing [9].…”
Section: Introductionmentioning
confidence: 99%
“…Monitoring of DDIs may improve the quality of prescribing and dispensing, and it might form a basis for education focused on appropriate prescribing [9]. Drug-Drug Interactions (DDIs) are estimated to account for 6%-30% of all the adverse drug events, and they continue to pose a significant risk to the patient's health outcomes and a considerable economic burden on the healthcare system [8]. Hence, as they are an important hazard to the health of millions of patients, drug-drug interactions have to be tackled and it is the need of the hour.…”
Section: Introductionmentioning
confidence: 99%